248 related articles for article (PubMed ID: 30787927)
21. The mirrored methionine sulfoxide reductases of Neisseria gonorrhoeae pilB.
Lowther WT; Weissbach H; Etienne F; Brot N; Matthews BW
Nat Struct Biol; 2002 May; 9(5):348-52. PubMed ID: 11938352
[TBL] [Abstract][Full Text] [Related]
22. High-affinity and cooperative binding of oxidized calmodulin by methionine sulfoxide reductase.
Xiong Y; Chen B; Smallwood HS; Urbauer RJ; Markille LM; Galeva N; Williams TD; Squier TC
Biochemistry; 2006 Dec; 45(49):14642-54. PubMed ID: 17144657
[TBL] [Abstract][Full Text] [Related]
23. Neisseria gonorrhoeae vaccine development: hope on the horizon?
Edwards JL; Jennings MP; Seib KL
Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
[TBL] [Abstract][Full Text] [Related]
24. Assessment of Serum Bactericidal and Opsonophagocytic Activity of Antibodies to Gonococcal Vaccine Targets.
Semchenko EA; Jen FE; Jennings MP; Seib KL
Methods Mol Biol; 2022; 2414():363-372. PubMed ID: 34784046
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of immunological responses to recombinant Porin A protein (rPoA) from native strains of Neisseria meningitidis serogroups A and B using OMV as an adjuvant in BALB/c mice.
Afrough P; Bouzari S; Mousavi SF; Asadi Karam MR; Vaziri F; Fateh A; Behrouzi A; Malekan M; Siadat SD
Microb Pathog; 2017 Nov; 112():209-214. PubMed ID: 28942175
[TBL] [Abstract][Full Text] [Related]
26. A strain-specific catalase mutation and mutation of the metal-binding transporter gene mntC attenuate Neisseria gonorrhoeae in vivo but not by increasing susceptibility to oxidative killing by phagocytes.
Wu H; Soler-García AA; Jerse AE
Infect Immun; 2009 Mar; 77(3):1091-102. PubMed ID: 19114548
[TBL] [Abstract][Full Text] [Related]
27. Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles.
Thomas CE; Zhu W; Van Dam CN; Davis NL; Johnston RE; Sparling PF
Infect Immun; 2006 Mar; 74(3):1612-20. PubMed ID: 16495532
[TBL] [Abstract][Full Text] [Related]
28. Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice.
Li G; Jiao H; Jiang G; Wang J; Zhu L; Xie R; Yan H; Chen H; Ji M
Clin Vaccine Immunol; 2011 Nov; 18(11):1817-22. PubMed ID: 21918113
[TBL] [Abstract][Full Text] [Related]
29. Leishmania major methionine sulfoxide reductase A is required for resistance to oxidative stress and efficient replication in macrophages.
Sansom FM; Tang L; Ralton JE; Saunders EC; Naderer T; McConville MJ
PLoS One; 2013; 8(2):e56064. PubMed ID: 23437085
[TBL] [Abstract][Full Text] [Related]
30. Methionine Sulfoxide Reductase A (MsrA) and Its Function in Ubiquitin-Like Protein Modification in
Fu X; Adams Z; Liu R; Hepowit NL; Wu Y; Bowmann CF; Moskovitz J; Maupin-Furlow JA
mBio; 2017 Sep; 8(5):. PubMed ID: 28874471
[TBL] [Abstract][Full Text] [Related]
31. Methionine sulfoxide reductase A protects against lipopolysaccharide-induced septic shock via negative regulation of the proinflammatory responses.
Singh MP; Kim KY; Kwak GH; Baek SH; Kim HY
Arch Biochem Biophys; 2017 Oct; 631():42-48. PubMed ID: 28803836
[TBL] [Abstract][Full Text] [Related]
32. Gonococcal microparticle vaccine in dissolving microneedles induced immunity and enhanced bacterial clearance in infected mice.
Bagwe P; Bajaj L; Menon I; Braz Gomes K; Kale A; Patil S; Vijayanand S; Gala R; D'Souza MJ; Zughaier SM
Int J Pharm; 2023 Jul; 642():123182. PubMed ID: 37369287
[TBL] [Abstract][Full Text] [Related]
33. Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
Gulati S; Shaughnessy J; Ram S; Rice PA
Front Immunol; 2019; 10():321. PubMed ID: 30873172
[TBL] [Abstract][Full Text] [Related]
34. Progress Toward a Gonococcal Vaccine: The Way Forward.
Russell MW; Jerse AE; Gray-Owen SD
Front Immunol; 2019; 10():2417. PubMed ID: 31681305
[TBL] [Abstract][Full Text] [Related]
35. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.
Ogawa F; Shimizu K; Hara T; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Takehara K; Sato S
Arch Dermatol Res; 2010 Jan; 302(1):27-35. PubMed ID: 19844733
[TBL] [Abstract][Full Text] [Related]
36. Recombinant truncated AniA of pathogenic Neisseria elicits a non-native immune response and functional blocking antibodies.
Shewell LK; Ku SC; Schulz BL; Jen FE; Mubaiwa TD; Ketterer MR; Apicella MA; Jennings MP
Biochem Biophys Res Commun; 2013 Feb; 431(2):215-20. PubMed ID: 23313483
[TBL] [Abstract][Full Text] [Related]
37. Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations.
Wetzler LM; Blake MS; Gotschlich EC
J Exp Med; 1988 Nov; 168(5):1883-97. PubMed ID: 3141555
[TBL] [Abstract][Full Text] [Related]
38. Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.
Zielke RA; Wierzbicki IH; Baarda BI; Gafken PR; Soge OO; Holmes KK; Jerse AE; Unemo M; Sikora AE
Mol Cell Proteomics; 2016 Jul; 15(7):2338-55. PubMed ID: 27141096
[TBL] [Abstract][Full Text] [Related]
39. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
[TBL] [Abstract][Full Text] [Related]
40. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.
Gulati S; Mu X; Zheng B; Reed GW; Ram S; Rice PA
J Infect Dis; 2015 Jul; 212(2):311-5. PubMed ID: 25596304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
